Quick Update for The Cooper Companies (COO) Investors

Shares of Healthcare sector company The Cooper Companies moved 0.7% today, and are now trading at a price of $344.89. The large-cap stock's daily volume was 149,930 compared to its average volume of 336,290. The S&P 500 index returned a 1.6% performance.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company is based in San Ramon and has 14,000 full time employees. Its market capitalization is $17,021,839,360. The Cooper Companies currently offers its equity investors a dividend that yields 0.0% per year.

13 analysts are following The Cooper Companies and have set target prices ranging from $280 to $560 per share. On average, they have given the company a rating of buy. At today's prices, COO is trading -3.7% away from its average analyst target price of $358.15 per share.

Over the last year, COO shares have gone down by -11.8%, which represents a difference of -0.5% when compared to the S&P 500. The stock's 52 week high is $430.67 per share and its 52 week low is $244.22. With average free cash flows of $392,975,000.0 that have been growing at an average rate of 41.8% over the last four years, The Cooper Companies declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ MM) Capital expenditures ($ MM) Free Cash Flow ($ MM) YoY Growth (%)
2022-10-31 692 -242 450 -14.08
2021-10-31 739 -214 524 197.5
2020-10-31 487 -310 176 -58.16
2019-10-31 713 -292 421 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.